Carmelo Laface

Cuneo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Predictors of duration of hospital stay for cancer patients admitted due to medical causes: A quality-improvement evaluation.

Predictors of duration of hospital stay for cancer patients admitted due to medical causes: A quality-improvement evaluation.

Journal: Tumori

Published: October 18, 2025

Corneal Perforation as a Possible Ocular Adverse Event Caused by Cabozantinib: A Clinical Case and Brief Review.

Corneal Perforation as a Possible Ocular Adverse Event Caused by Cabozantinib: A Clinical Case and Brief Review.

Journal: Journal of clinical medicine

Published: May 07, 2025

Long-term survival in a male patient with Müllerian adenocarcinoma of the pelvis: a 15-year case report.

Long-term survival in a male patient with Müllerian adenocarcinoma of the pelvis: a 15-year case report.

Journal: Frontiers in oncology

Published: April 12, 2025

Successful Treatment of MEK Inhibitor-Induced Paronychia in Neurofibromatosis with Photodynamic Therapy: A Case Report and Review of the Therapeutic Options.

Successful Treatment of MEK Inhibitor-Induced Paronychia in Neurofibromatosis with Photodynamic Therapy: A Case Report and Review of the Therapeutic Options.

Journal: Journal of clinical medicine

Published: January 21, 2025

Immunobiology of biliary tract cancer and recent clinical findings in approved and upcoming immune checkpoint inhibitors.

Immunobiology of biliary tract cancer and recent clinical findings in approved and upcoming immune checkpoint inhibitors.

Journal: Expert opinion on biological therapy

Published: November 15, 2024

Lichenoid dermatitis induced by abemaciclib in a patient with HR+/HER2- breast cancer.

Lichenoid dermatitis induced by abemaciclib in a patient with HR+/HER2- breast cancer.

Journal: Dermatology reports

Published: October 01, 2024

Autotaxin-Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic Implications.

Autotaxin-Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic Implications.

Journal: International journal of molecular sciences

Published: May 30, 2024

Pembrolizumab-Induced Rupioid Psoriasis Treated by Apremilast Without Interrupting the Ongoing Antineoplastic Treatment.

Pembrolizumab-Induced Rupioid Psoriasis Treated by Apremilast Without Interrupting the Ongoing Antineoplastic Treatment.

Journal: Cureus

Published: February 29, 2024

What the future holds: BBT-176, beyond third-generation EGFR tyrosine kinase inhibitors.

What the future holds: BBT-176, beyond third-generation EGFR tyrosine kinase inhibitors.

Journal: Translational lung cancer research

Published: November 29, 2023

Antibody-Drug Conjugates in HR+ Breast Cancer: Where Are We Now and Where Are We Heading?

Antibody-Drug Conjugates in HR+ Breast Cancer: Where Are We Now and Where Are We Heading?

Journal: Journal of clinical medicine

Published: October 20, 2023

Tattoo-Associated Skin Reaction in a Melanoma Patient Receiving B-RAF and MEK Inhibitors: A Case Report with an Emphasis on Etiopathogenic and Histological Features.

Tattoo-Associated Skin Reaction in a Melanoma Patient Receiving B-RAF and MEK Inhibitors: A Case Report with an Emphasis on Etiopathogenic and Histological Features.

Journal: Journal of clinical medicine

Published: October 13, 2023

Clinical Updates for Gastrointestinal Malignancies.

Clinical Updates for Gastrointestinal Malignancies.

Journal: Journal of personalized medicine

Published: September 18, 2023

Showing 1-12 of 41

Last Updated: 09/26/2026